Fidelity Investments’s Seaport Therapeutics SPTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SPTX
Fidelity Investments's SPTX Position: Q3 2026 in Review
Fidelity Investments increased its Seaport Therapeutics (SPTX) stake by 55% in Q3 2026, buying an estimated $14.5M and bringing the position to 1,837,672 shares worth $37.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1630.
Fidelity Investments first reported a position in SPTX in Q2 2026 and has held it in 2 quarters since. 74 funds tracked by Wall St. Rank hold SPTX as of Q3 2026.
- Fidelity Investments held 1,837,672 shares of Seaport Therapeutics worth $37.1M as of Q3 2026.
- Fidelity Investments bought 652,572 Seaport Therapeutics shares in Q3 2026, an estimated $14.5M.
- Seaport Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #1630 holding.
- Fidelity Investments first reported a position in Seaport Therapeutics in Q2 2026 and has held it in 2 quarters since.
- 74 funds tracked by Wall St. Rank held Seaport Therapeutics as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.